About 210,000 results
Open links in new tab
  1. Staying Up to Date with COVID-19 Vaccines | Covid | CDC

    Nov 19, 2025 · Importance of staying up to date Getting the 2025–2026 COVID-19 vaccine is important because: Protection from the COVID-19 vaccine decreases with time. Immunity after COVID-19 …

  2. Overview of COVID-19 Vaccines and Vaccination | Covid | CDC

    Nov 4, 2025 · Learn about types of COVID-19 vaccines and find recommendations, dosage, and overview of schedule.

  3. 2025–2026 COVID-19 Vaccination Guidance | Covid | CDC

    Nov 4, 2025 · The 2025–2026 COVID-19 vaccine is recommended for people ages 6 months and older based on individual-based decision-making (also known as shared clinical decision making). The …

  4. Polio Vaccine Recommendations | Polio | CDC

    Sep 6, 2024 · Adults who have had 3 or more doses of polio vaccine in the past and are at increased risk of exposure to poliovirus may receive one lifetime booster dose of IPV.

  5. Booster Seat Planning Guide | Child Passenger Safety | CDC

    Aug 14, 2025 · CDC's Booster Seat Planning Guide can assist states, tribes, localities, and territories with assessing, planning, and implementing improved booster seat laws to reduce crash injuries and …

  6. Getting Your COVID-19 Vaccine | COVID-19 | CDC

    Jun 11, 2025 · Learn how to schedule an appointment to get your COVID-19 vaccine and know what to expect at your appointment.

  7. CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for …

    October 23, 2024 - Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices' (ACIP) recommendation for people 65 years and older and those who are …

  8. ACIP Evidence to Recommendations for Use of COVID-19 Vaccine …

    Aug 27, 2024 · Any FDA-approved or authorized COVID-19 vaccine (Pfizer-BioNTech, Moderna, or Janssen) can be used as the booster dose, at an interval of at least 2 months since the primary …

  9. Safety Considerations for COVID-19 Vaccines | Covid | CDC

    Nov 4, 2025 · Safety considerations for COVID-19 vaccines In clinical trials of COVID-19 vaccines, post-vaccination reactions were generally similar. While the frequency of some reactions varied by age, …

  10. Surveillance and Data Analytics | COVID-19 | CDC

    Sep 5, 2025 · COVID-19 Surveillance Data in the United States Early Indicators Test positivity (the percentage of total reported tests that are positive) and the percentage of total emergency …